PLRX
Pliant Therapeutics Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Pliant Therapeutics is a biotechnology company focused on developing therapies for the treatment of fibrotic diseases.
Pliant Therapeutics Inc
PLRX
Pliant Therapeutics is a biotechnology company focused on developing therapies for the treatment of fibrotic diseases.
Price history of Pliant Therapeutics Inc
Price history of Pliant Therapeutics Inc
Performance & Momentum
Strategic Analysis
Pliant Therapeutics Inc • 2026
Pliant Therapeutics is a clinical-stage biopharmaceutical company focused on fibrotic and pulmonary diseases, with an approach based on targeted therapies. Its positioning relies on developing differentiated drug candidates in indications where medical needs remain significant and therapeutic options are limited.
- Clear focus on fibrosis and pulmonary conditions, markets with strong unmet medical demand
- Targeted therapy approach, easier for investors to understand than highly diversified biotech platforms
- Significant value-creation potential in the event of clinical or regulatory success
- High dependence on clinical trial outcomes and regulatory decisions
- Valuation profile weakened by a prolonged downtrend in the stock, reflecting a sharp loss of market confidence
Momentum is very weak and the underlying trend remains clearly negative, suggesting elevated risk perception and limited short-term visibility. In the absence of recent news to revive the story, the stock retains a speculative profile, highly dependent on a credible clinical catalyst to reverse the trend.
Similar stocks to Pliant Therapeutics Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
